WuXi XDC

Thought Leadership: Dr. Jun Hu, Vice President, Head of Client Enabling Center of Excellence & Head of Singapore Site Management at WuXi XDC, was recently invited by IMAPAC to discuss key insights in the field of ADC & Bioconjugates. 💡 Challenges in ADC development – Key considerations at various stages, including CMC development and manufacturing obstacles 💡 The Role of CRO/CDMOs – How CRO/CDMOs enable ADC development and what to look for when choosing the right partner 💡 WuXi XDC as a global leading CRDMO – The indispensable value WuXi XDC brings to the industry 💡 Singapore Site Strategy – Insights into the strategic progress of WuXi XDC’s new Singapore facility 💡 Future of ADCs – Dr. Hu’s perspective on current trends and future prospects in ADC and bioconjugates development View the full interview here 👉 https://lnkd.in/gu2dY2bH

📣 Join Us for an Exclusive Webinar on Accelerating ADC & XDC Development with Novel Linker Technologies！Register now to secure your spot: https://lnkd.in/gYv8Cnyw Mark your calendars for March 27th and don’t miss our upcoming webinar: “Bridging ‘Small’ Molecules with ‘Big’ Molecules: Accelerating ADCs & XDCs Discovery and Development with Novel Linker Technologies.” Led by Dr. Jingjie Huang, this session is a must-attend for anyone exploring the cutting edge of linker/connector technologies. Dr. Huang will dive into innovative linker technologies that can modulate the physicochemical properties of ADCs and XDCs, enhancing their druggability and significantly accelerating discovery and development timelines. This is your opportunity to gain valuable insights and stay ahead in the rapidly evolving field of bioconjugates. 💡 Webinar: Bridging “Small” Molecules with “Big” Molecules: Accelerating ADCs & XDCs Discovery and Development with Novel Linker Technologies 👤 Speaker: Dr. Jingjie Huang, Head of Payload-Linker Discovery Service, WuXi XDC 📅 March 27, 11:00 AM EDT, 4:00 PM CET #linker #conjugate #conjugates #bioconjugation #bioconjugate #bioconjugates #adc #adcs #antibodydrugcongugate #antibodydrugcongugates #cmc #cdmo #crdmo #biomanufacturing #bioprocessing

Join us in celebrating WuXi XDC's spectacular triumphs at the 2025 Asia - Pacific Biopharma Excellence Awards！IMAPAC WuXi XDC has been recognized with four prestigious awards: 🏆 Best ADC CDMO in China 🏆 Best ADC CDMO in Asia 🏆 Best ADC CRO in Asia 🏆 Best ADC Platform Technology We are honored to receive these prestigious awards, which not only reaffirm our team’s relentless pursuit of excellence and innovation in the ADC field but also underscore our dedication to delivering world-class services that empower our clients to bring novel therapies to patients worldwide. Looking ahead, WuXi XDC will continue to support our clients and advance the innovation and progress of the global bioconjugate industry！ #conjugate #bioconjugate #antibodydrugcongugate #cmc #cdmo #crdmo #biomanufacturing #bioprocessing

WuXi XDC Cayman Inc. (“WuXi XDC”, or the “Company”, stock code: 2268.HK), a leading global CRDMO (Contract Research, Development, and Manufacturing Organization) specializing in antibody-drug conjugates (ADCs) and other bioconjugates, has been honored with four prestigious awards at the Asia-Pacific Biopharma Excellence Awards 2025 IMAPAC. The Asia-Pacific Biopharma Excellence Awards honor companies annually that have exhibited outstanding performance and achievement in the biopharmaceutical sector. These accolades underscore WuXi XDC’s leadership, innovation, and fully integrated CRDMO platform, empowering global clients from early discovery to commercial manufacturing. More detailed information about this collaboration is available from the following link. https://shorturl.at/aa3gT

🎉 Celebrating Innovation at the 53rd Organic Process Research & Development Conference! Scientific Update Ltd This week, we had the honor of sponsoring and participating in the 53rd Organic Process Research & Development Conference in Charleston, SC, USA. It was an incredible opportunity to connect with industry leaders, showcase cutting-edge advancements, and explore the future of organic process research. Engaging in meaningful discussions, sharing breakthrough insights, and building valuable partnerships reaffirmed our commitment to driving innovation in this dynamic field. We are proud to have been part of such a prestigious event and to contribute to the ongoing evolution of the industry. Let’s continue the conversation and stay connected! Reach out to us at: https://lnkd.in/eCgHTVqf #OPRD #conjugate #conjugates #bioconjugation #bioconjugate #bioconjugates #adc #adcs #antibodydrugcongugate #antibodydrugcongugates #cmc #cdmo #crdmo #biomanufacturing #bioprocessing #PayloadLinker

Join Us at CPHI Japan in Tokyo – April 9-11 We are excited to invite you to CPHI Japan, taking place in Tokyo from April 9 to 11. Don’t miss the opportunity to hear from Dr. Xudong Wei, Senior Vice President and Head of Payload Linker PD & Manufacturing at WuXi XDC, as he delivers an insightful presentation on April 9. Dr. Wei’s session, titled “Synthesis of Payload-Linkers for Conjugated Drugs: Key Elements of Successful CMC Work,” will provide in-depth and practical knowledge on the synthesis of payload-linkers—a critical component in the development of conjugated drugs. He will also share valuable insights into the key factors that drive successful Chemistry, Manufacturing, and Controls (CMC) strategies. We look forward to connecting with you at the event! Let’s schedule a meeting to discuss how we can collaborate: https://lnkd.in/guvvwrnY #CPHI #conjugate #conjugates #bioconjugation #bioconjugate #bioconjugates #adc #adcs #antibodydrugcongugate #antibodydrugcongugates #cmc #cdmo #crdmo #biomanufacturing #bioprocessing #PayloadLinker

WuXi XDC Cayman Inc. (“WuXi XDC” or the “Company”, stock code: 2268.HK), a leading global CRDMO (Contract Research, Development, and Manufacturing Organization) specializing in antibody-drug conjugates (ADCs) and other bioconjugates (XDCs), today announced the signing of a Memorandum of Understanding (MOU) with AbTis AbTis | 앱티스, a leading ADC biotechnology company based in South Korea. This partnership brings together AbTis' proprietary site-selective conjugation platform AbClick® and WuXi XDC's integrated discovery services and all-in-one development & manufacturing platform. The collaboration aims to accelerate ADC therapeutic innovation by integrating AbTis' cutting-edge technology into WuXi XDC's toolbox, while fostering new opportunities for global clients. More detailed information about this collaboration is available from the following link. https://lnkd.in/gUtDc_bm

Our amazing team of experts is onsite at the prestigious 53rd Organic Process Research & Development Conference, taking place in the dynamic city of Charleston, SC, USA! 🌟 Dr. Sudhir Patil, Satish Nagaraj If you're also attending this exciting event, we warmly invite you to drop by our booth. Whether you're looking for strategic partnerships, have a complex project in mind, or simply want to explore the latest industry trends with like - minded professionals, our team is eager to engage in meaningful conversations. 🤝 Come and discuss your project needs with us. We're here to offer our expertise, and help you chart the best course for your R&D endeavors. Schedule a chat with us using this link: https://lnkd.in/guvvwrnY #OPRD #conjugate #conjugates #bioconjugation #bioconjugate #bioconjugates #adc #adcs #antibodydrugcongugate #antibodydrugcongugates #cmc #cdmo #crdmo #biomanufacturing #bioprocessing #PayloadLinker

Get ready for the ADC Asia Congress 2025 IMAPAC in Singapore? If so, don't miss the presentation by Dr. Jun Hu, Vice President, Head of Client Enabling Center of Excellence & Head of Singapore Site Management at WuXi XDC, on March 12th. Dr. Hu will share deep-dive insights in his presentation titled "Accelerate Bioconjugate Development with WuXi XDC’s Fully Integrated Capabilities and Expanding Global Capacity." Join Dr. Hu's talk to learn more about👉 1）The booming momentum of ADC and XDC development in the worldwide pharmaceutical industry. 2）WuXi XDC‘s integrated service and innovative technology platform to accelerate bioconjugate development. 3）Speed up of global footprint expansion of WuXi XDC to enable global partners. Schedule a chat now ▶️ https://lnkd.in/guvvwrnY #conjugate #conjugates #bioconjugation #bioconjugate #bioconjugates #adc #adcs #antibodydrugcongugate #antibodydrugcongugates #cmc #cdmo #crdmo #biomanufacturing #bioprocessing

The World ADC LONDON World ADC Event Series this week served as a remarkable gathering, triumphantly bringing together the leading experts in the bioconjugates industry. Our team had an incredibly productive experience here, we would like to extend our sincere appreciation to each of you who attended the presentation, "Expediting Development of Novel ADCs through WuXi XDC’s Innovative Technology Platform and Fully Integrated CMC Services," expertly delivered by Dr. Marie Zhu, our company's CTO. Moreover, we’re also thankful to each of you who dropped by our booth and posters. It was a perfect platform for connecting with industry pioneers and sharing our forward - looking views on the bioconjugation field. We look forward to continuing our connection with you. You can reach out through: https://lnkd.in/eCgHTVqf